title: [Neuroendocrine tumor therapy (NETTER-1) trial:177Lu-DOTA-TATE for neuroendocrine tumors].
authors.affiliation: Zentrum Radiologie, Klinik für Nuklearmedizin, Medizinische Hochschule Hannover, Carl-Neuberg-Str. 1, 30625, Hannover, Deutschland. Derlin.Thorsten@mh-hannover.de.
authors.forename: T
authors.initials: T
authors.lastname: Derlin
mesh_terms: D006801:Humans; D018358:Neuroendocrine Tumors / Q000532:radiotherapy*; D015282:Octreotide / Q000031:analogs & derivatives* / Q000627:therapeutic use; D009942:Organometallic Compounds / Q000627:therapeutic use*; D019275:Radiopharmaceuticals / Q000627:therapeutic use
chemical_list: D009942:Organometallic Compounds; D019275:Radiopharmaceuticals; C447941:lutetium Lu 177 dotatate; D015282:Octreotide